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a Serviç o de Pneumologia do Hospital Central do Funchal, Portugal
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Chronic pulmonary aspergillosis (CPA) is a rare disease, fre-
quently affecting patients with current or prior lung disease,
leading to the development of air cavities in the middle of lung
parenchyma. Chronic cavitary pulmonary aspergillosis (CCPA) is
the most common form of CPA, presenting as a single or as mul-
tiple pulmonary cavities with thickened walls, with or without
an aspergilloma inside. When not treated appropriately, it can
progress to chronic fibrosing pulmonary aspergillosis (CFPA), which
is characterized by severe fibrotic destruction of at least two lobes
of lung, ultimately leading to a major loss of lung function .1
These two forms of CPA, similarly to what happens to sin-
gle aspergilloma and Aspergillus nodules, usually occur in patients
who are not immunosuppressed, differently from what happens
in invasive pulmonary aspergillosis. On another hand, subacute
invasive aspergillosis (SAIA), previously named chronic necrotiz-
ing aspergillosis, contrasts from invasive pulmonary aspergillosis
due to its slower progression (usually 1–3 months), befaling in
mildly immunocompromised patients and having similar clinical
and radiological features to CCPA but a more rapid progression.1
We  report the case of a 44-year-old woman with bronchiec-
tasis due to whooping cough in childhood. She was referred
to an autoimmune diseases consultation due to a lower limb
vasculitis, whose study was negative except for anti-neutrophil
cytoplasmic antibodies (ANCAs – atypical pattern) of 1/160. She
started steroid therapy in considerable doses in order to con-
trol her disease. Chest X-rays demonstrated evolution of previous
lung lesions to aspergilloma and a six-month course of itracona-
zole was prescribed. Despite that, clear worsening of the lesions
with complete destruction of the left lung was perceived and the
patient was proposed for left pneumectomy. At the surgery, fill-
ing of the left pleural cavity with brown necrotic material was
observed. Histological exam of the surgical fragments revealed one
re-epithelized cavitated lesion associated with fungal structures
of the Aspergillus type. The microbiology of the surgical specimen
identified Aspergillus fumigatus.  Patient status after surgery has
improved (Fig. 1).
This case highlights the multiple forms of CPA. The progression
of this patient lesions do not fit the definition of SAIA, but we con-
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0300-2896/© 2021 SEPAR. Published by Elsevier España, S.L.U. All rights reserved.ig. 1. (a, b) X-ray evolution of the patient. The X-ray on the left (a) was  performed
efore corticosteroids therapy and the one on the right (b) about seven months after
he beginning of that therapy; (c, d) coronal and axial views of thoracic computed
omography performed after six months of Itraconazole, showing giant aspergilloma
n  left lung; (e, f) necrotic material of fungus ball observed during surgery.
ider that the new imunossupressive status contributed to a more
apidly progression from CCPA to CFPA.eference
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